Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Is a |
Product containing sulfacetamide (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Is a |
Product containing sulfathiazole (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Is a |
Product containing sulfabenzamide (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sulfabenzamide (substance) |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sulfacetamide (substance) |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sulfathiazole (substance) |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Is a |
Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has manufactured dose form |
Vaginal dose form (dose form) |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has manufactured dose form |
Vaginal tablet |
true |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Is a |
Product containing sulfacetamide in vaginal dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
Tablet (unit of presentation) |
true |
Inferred relationship |
Some |
2 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has presentation strength numerator value |
144 |
false |
Inferred relationship |
Some |
1 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
Tablet (unit of presentation) |
true |
Inferred relationship |
Some |
3 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Count of base of active ingredient |
trois |
false |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
2 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
2 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
Tablet (unit of presentation) |
true |
Inferred relationship |
Some |
1 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
3 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
3 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Sulfacetamide sodium |
true |
Inferred relationship |
Some |
1 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has unit of presentation |
Tablet (unit of presentation) |
true |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Sulfacetamide sodium |
true |
Inferred relationship |
Some |
1 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Is a |
Sulfabenzamide and sulfacetamide and sulfathiazole only product in vaginal dose form |
true |
Inferred relationship |
Some |
|
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has presentation strength numerator value |
172 |
false |
Inferred relationship |
Some |
3 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Sulfathiazole (substance) |
true |
Inferred relationship |
Some |
3 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has presentation strength numerator value |
184 |
false |
Inferred relationship |
Some |
2 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Sulfabenzamide (substance) |
true |
Inferred relationship |
Some |
2 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Sulfabenzamide (substance) |
true |
Inferred relationship |
Some |
2 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Sulfathiazole (substance) |
true |
Inferred relationship |
Some |
3 |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|